Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
about
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).The epidermal growth factor receptor pathway in chronic kidney diseases.EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats.
P2860
Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@ast
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@en
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@nl
type
label
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@ast
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@en
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@nl
prefLabel
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@ast
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@en
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@nl
P2093
P2860
P1433
P1476
Erlotinib preserves renal func ...... ubicin treated nephrotic rats.
@en
P2093
Janet D Klein
Jeff M Sands
Raed N Bou Matar
P2860
P304
P356
10.1371/JOURNAL.PONE.0054738
P407
P577
2013-01-18T00:00:00Z